Found: 7
Select item for more details and to access through your institution.
CYP3A Mediates an Unusual C(sp<sup>2</sup>)−C(sp<sup>3</sup>) Bond Cleavage via Ipso‐Addition of Oxygen in Drug Metabolism.
- Published in:
- Angewandte Chemie, 2024, v. 136, n. 23, p. 1, doi. 10.1002/ange.202405197
- By:
- Publication type:
- Article
CYP3A Mediates an Unusual C(sp<sup>2</sup>)−C(sp<sup>3</sup>) Bond Cleavage via Ipso‐Addition of Oxygen in Drug Metabolism.
- Published in:
- Angewandte Chemie International Edition, 2024, v. 63, n. 23, p. 1, doi. 10.1002/anie.202405197
- By:
- Publication type:
- Article
Advancing ASMS with LC‐MS/MS for the discovery of novel PDCL2 ligands from DNA‐encoded chemical library selections.
- Published in:
- Andrology, 2023, v. 11, n. 5, p. 808, doi. 10.1111/andr.13309
- By:
- Publication type:
- Article
The testis-specific E3 ubiquitin ligase RNF133 is required for fecundity in mice.
- Published in:
- BMC Biology, 2022, v. 20, n. 1, p. 1, doi. 10.1186/s12915-022-01368-2
- By:
- Publication type:
- Article
Targeting the OXE receptor with a selective antagonist inhibits allergen‐induced pulmonary inflammation in non‐human primates.
- Published in:
- British Journal of Pharmacology, 2022, v. 179, n. 2, p. 322, doi. 10.1111/bph.15721
- By:
- Publication type:
- Article
Inhibition of allergen-induced dermal eosinophilia by an oxoeicosanoid receptor antagonist in non-human primates.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Novel highly potent OXE receptor antagonists with prolonged plasma lifetimes that are converted to active metabolites in vivo in monkeys.
- Published in:
- 2020
- By:
- Publication type:
- journal article